EEEkaterina Egorova

Ekaterina Egorova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekaterina Egorova has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serotypes, Clonality, and Virulence Gene Distribution in Streptococcus agalactiae Isolates recovered in Russian Federation in 2021–2024

    by E. A. Egorova, Y. N. Urban, A. L. Bayrakova, O. G. Grechishnikova, V. A. Kuzmenok, E. A. Voropaeva, E V. Rumiantseva, P. V. Mitkovets

    Background . Streptococcus agalactiae (Group B Streptococcus, GBS) remains a leading cause of severe perinatal infections. The key features of S. agalactiae population in Russia remain underexplored, necessitating comprehensive molecular surveillance. Aim . This study aimed to perform a comprehensive analysis of the serotype distribution, clonality, and prevalence of genetic virulence determinants in S. agalactiae isolates recovered in Russia in 2021–2024. Materials and Methods . We analysed 72 non-invasive S. agalactiae isolates. The isolates were collected in Northwestern Federal District between 2021 and 2024 from patients (30 males and 42 females, aged 18–55 years). We recovered the isolates from vaginal, cervical, and urethral swabs, urine, prostate secretion, and semen. We performed initial species identification by standard bacteriological methods, latex agglutination and PCR. The isolates were whole-genome sequenced. We used bioinformatic analysis to derive serotypes, multi-locus sequence types (ST), clonal complexes (CC) and virulence genes from genome data. Results and Discussion . Our data revealed that serotypes V (34.7 %), Ia (22.2%), and III (22.2 %) were predominant, collectively accounting for 79.1 % of the isolates. The isolates exhibited high genetic diversity, comprising 22 sequence types (STs) grouped into 7 clonal complexes (CCs). The dominant CCs were CC1 (29.2 %), CC23 (23.6 %), CC19 (19.4 %), and CC17 (12.5 %). The most prevalent pilus genotype was PI-1+PI-2a1 (36%). The genes encoding surface protein Srr1 and Alp-like proteins were detected in 80.6% and 58% of isolates, respectively. The isolated of hypervirulent CC17 complex carried hvgA, srr2, and rib genes. Conclusion . We found that the S. agalactiae isolates exhibited high genetic diversity, with predominant serotypes V, Ia, and III and clonal complexes CC1, CC23, CC19, and CC17. Our analysis revealed a prevalence (12.5%) of the hypervirulent CC17 clone, confirming the circulation of high-risk strains associated with neonatal invasive disease. Our results indicate that a hexavalent conjugate vaccine would likely cover a majority of the circulating strains. We identified specific virulence gene profiles and their association with certain clonal complexes. Our results suggest that the revealed virulence factors are promising targets for serotype-independent vaccine development.

  • Open Access

    Key features of pneumococcal isolates recovered in Central and Northwestern Russia in 2011–2018 determined through whole-genome sequencing

    by Ekaterina Egorova, Narender Kumar, Rebecca A. Gladstone, Yulia Urban, Elena Voropaeva, A.V. Chaplin, Elena Rumiantseva, T. S. Svistunova, Paulina A. Hawkins, Keith P. Klugman, et al.

    Invasive pneumococcal disease remains one of the leading causes of morbidity and mortality worldwide. In Russia, 13- valent pneumococcal conjugate vaccine (PCV13) was introduced into the childhood immunization programme nationwide in 2014. As part of the Global Pneumococcal Sequencing Project (GPS), we used genome data to characterize 179 pneumococcal isolates collected from Russia in 2011–2018 to investigate the circulating pneumococcal strains using a standardized genomic definition of pneumococcal lineages (global pneumococcal sequence clusters, GPSCs), prevalent serotypes and antimicrobial resistance profiles. We observed high serotype and lineage diversity among the 179 isolates recovered from cerebrospinal fluid (n=77), nasopharyngeal swabs (n=99) and other non-sterile site swabs (n=3). Overall, 60 GPSCs were identified, including 48 clonal complexes (CCs) and 14 singletons, and expressed 42 serotypes (including non-typable). Among PCV13 serotypes, 19F, 6B and 23F were the top three serotypes while 11A, 15B/C and 8 were the top three among non-PCV13 serotypes in the collection. Two lineages (GPSC6 and GPSC47) expressed both PCV13 and non-PCV13 serotypes that caused invasive disease, and were penicillin- and multidrug-resistant (MDR), highlighting their potential to adapt and continue to cause infections under vaccine and antibiotic selective pressure. PCV13 serotypes comprised 92 % (11/12) of the CSF isolates from the children aged below 5 years; however, the prevalence of PCV13 serotype isolates dropped to 53 % (31/58) among the nasopharyngeal isolates. Our analysis showed that 59 % (105/179) of the isolates were predicted to be non-susceptible to at least one class of antibiotics and 26 % (46/179) were MDR. Four MDR lineages (GPSC1, GPSC6, GPSC10 and GPSC47) accounted for 65 % (30/46) of the MDR isolates and expressed PCV13 serotypes (93 %, 28/30). This study provides evidence of high genetic and serotype diversity contributed by a mix of globally spreading and regionally circulating lineages in Russia. The observations suggest that the PCV13 vaccine could be important in reducing both invasive disease and antimicrobial resistance. We also identify potential lineages (GPSC6 and GPSC47) that may evade the vaccine.


  • Open Access

    Antifungal Activity, Structural Stability, and Immunomodulatory Effects on Human Immune Cells of Defensin from the Lentil Lens culinaris

    by Ekaterina I. Finkina, Ivan V. Bogdanov, Anastasia A. Ignatova, Marina D. Kanushkina, Ekaterina A. Egorova, Alexander D. Voropaev, Elena A. Stukacheva, Tatiana V. Ovchinnikova

    An increase in the frequency of mycoses and spreading of multidrug-resistant fungal pathogens necessitates the search for new antifungal agents. Earlier, we isolated the novel defensin from lentil Lensculinaris seeds, designated as Lc-def, which inhibited the growth of phytopathogenic fungi. Here, we studied an antifungal activity of Lc-def against human pathogenic Candida species, structural stability of the defensin, and its immunomodulatory effects that may help to prevent fungal infection. We showed that Lc-def caused 50% growth inhibition of clinical isolates of Candida albicans, C. krusei, and C. glabrata at concentrations of 25–50 μM, but was not toxic to different human cells. The lentil defensin was resistant to proteolysis by C. albicans and was not cleaved during simulated gastroduodenal digestion. By using the multiplex xMAP assay, we showed for the first time for plant defensins that Lc-def increased the production of such essential for immunity to candidiasis pro-inflammatory cytokines as IL-12 and IL-17 at the concentration of 2 μM. Thus, we hypothesized that the lentil Lc-def and plant defensins in general may be effective in suppressing of mucocutaneous candidiasis due to their antifungal activity, high structural stability, and ability to activate a protective immune response.


  • Open Access

    A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV

    by Kedibone M. Ndlangisa, Mignon du Plessis, Stephanie Lo, Linda de Gouveia, Chrispin Chaguza, Martin Antonio, Brenda Kwambana-Adams, Jennifer Cornick, Dean B. Everett, Ron Dagan, et al.

    Pneumococcal serotype 35B is an important non-conjugate vaccine (non-PCV) serotype. Its continued emergence, post-PCV7 in the USA, was associated with expansion of a pre-existing 35B clone (clonal complex [CC] 558) along with post-PCV13 emergence of a non-35B clone previously associated with PCV serotypes (CC156). This study describes lineages circulating among 35B isolates in South Africa before and after PCV introduction. We also compared 35B isolates belonging to a predominant 35B lineage in South Africa (GPSC5), with isolates belonging to the same lineage in other parts of the world. Serotype 35B isolates that caused invasive pneumococcal disease in South Africa in 2005–2014 were characterized by whole-genome sequencing (WGS). Multi-locus sequence types and global pneumococcal sequence clusters (GPSCs) were derived from WGS data of 63 35B isolates obtained in 2005–2014. A total of 262 isolates that belong to GPSC5 (115 isolates from South Africa and 147 from other countries) that were sequenced as part of the global pneumococcal sequencing (GPS) project were included for comparison. Serotype 35B isolates from South Africa were differentiated into seven GPSCs and GPSC5 was most common (49 %, 31/63). While 35B was the most common serotype among GPSC5/CC172 isolates in South Africa during the PCV13 period (66 %, 29/44), 23F was the most common serotype during both the pre-PCV (80 %, 37/46) and PCV7 period (32 %, 8/25). Serotype 35B represented 15 % (40/262) of GPSC5 isolates within the global GPS database and 75 % (31/40) were from South Africa. The predominance of the GPSC5 lineage within non-vaccine serotype 35B, is possibly unique to South Africa and warrants further molecular surveillance of pneumococci.